A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants.

Autor: Ok Baik, Yeong¹ (AUTHOR), Lee, Youngjin¹ (AUTHOR), Lee, Chankyu² (AUTHOR), Kyung Kim, Soo² (AUTHOR), Park, Jooyoung¹ (AUTHOR), Sun, Meixiang² (AUTHOR), Jung, DaYe¹ (AUTHOR), Young Jang, Jin² (AUTHOR), Jun Yong, Tae² (AUTHOR), Woo Park, Jeong³ (AUTHOR), Jeong, Sungho³ (AUTHOR), Lim, Suwon³ (AUTHOR), Hyun Han, Seung³ (AUTHOR), Keun Choi, Seuk¹ (AUTHOR) skchoi1027@eubiologics.com

Publikováno v: Vaccine. Mar2023, Vol. 41 Issue 10, p1753-1759. 7p.